Vertical: CNMBase Year: 2025
Market Size (2025)
$420.13M
Projected (2032)
$600.49M
CAGR (2022–2032)
5.2%
Key Players
10+
Market Overview
The Global Feed Prebiotics Market is valued at USD 420.13 Million in 2025 and is projected to reach USD 600.49 Million by 2032, expanding at a CAGR of 5.23% during 2026–2032. The market has grown steadily from USD 360.39 Million in 2022, and the forecast period adds an absolute increment of USD 180.36 Million between 2025 and 2032. Growth is underpinned by the continuing withdrawal of antibiotic growth promoters from livestock production, the expansion of poultry and swine output in emerging economies, and the increasing emphasis that integrators and compound feed manufacturers place on gut health as a lever for feed conversion, uniformity and disease resilience.
Feed prebiotics are non-digestible carbohydrates, chiefly mannan oligosaccharides derived from yeast cell walls, inulin and fructo-oligosaccharides derived from chicory root or sucrose, and a group of other oligosaccharides and beta-glucans, that are added to animal diets to support a beneficial intestinal microbiota. Their adoption has moved from a niche, premium additive to a mainstream component of antibiotic-free and reduced-antibiotic feeding programmes, frequently used alongside probiotics, organic acids, enzymes and phytogenic additives.
Key Findings
Product Type: Mannan Oligosaccharides is the largest product type, accounting for 40.0% of the market in 2025 (USD 168.05 Million). The Others segment is the fastest-growing product type, with a CAGR of 6.54% during 2026–2032.
Livestock: Poultry is both the largest and the fastest-growing livestock segment, holding 45.0% of the market in 2025 (USD 189.06 Million) and expanding at a CAGR of 5.84%.
Region: Asia Pacific is the leading region with a 32.0% share in 2025 (USD 134.44 Million), while Middle East & Africa is the fastest-growing region with a CAGR of 6.40%.
Country: The U.S. is the largest country market at USD 72.09 Million in 2025, equivalent to 17.2% of global demand. India is the fastest-growing country market, with a CAGR of 7.48% during 2026–2032.
Absolute opportunity: Asia Pacific contributes the largest absolute increment of any region between 2025 and 2032 (USD 69.61 Million), followed by Europe (USD 39.04 Million) and North America (USD 33.03 Million).
Segmentation Summary
By Product Type: Mannan Oligosaccharides (USD 168.05 Million in 2025) leads the market owing to the long commercial track record of yeast cell wall products in poultry and swine diets and the wide availability of yeast by-product streams from brewing, ethanol and baker's yeast production. Inulin & FOS (USD 126.04 Million, 30.0%) is well established in Europe, where chicory inulin and short-chain FOS production is concentrated. The Others segment (USD 126.04 Million, 30.0%), which covers oligosaccharides such as galacto-, xylo- and chito-oligosaccharides and purified beta-glucans, records the highest growth at a CAGR of 6.54% as newer, more targeted glycan products gain acceptance.
By Livestock: Poultry (USD 189.06 Million) dominates demand because broiler and layer production is the fastest-expanding source of animal protein worldwide and because antibiotic-free broiler programmes rely heavily on gut-health additives. Swine (USD 126.04 Million, 30.0%) is the second-largest segment, supported by the need to manage post-weaning gut disorders, while the Others segment (USD 105.03 Million, 25.0%), which includes ruminants, aquaculture and other species, grows at a CAGR of 5.45%.
By Region: Asia Pacific (32.0%) and Europe (28.0%) together account for 60.0% of the 2025 market. North America holds 22.0%, Latin America 13.0% and Middle East & Africa 5.0%. Growth rates are highest in Middle East & Africa (6.40%), Asia Pacific (6.11%) and Latin America (5.90%), and lowest in the mature European market (4.20%).
Competitive Landscape Summary
The market is moderately fragmented. A small group of fermentation and yeast specialists, notably Alltech, Phileo by Lesaffre and Lallemand Animal Nutrition, hold leading positions in the Mannan Oligosaccharides segment through branded yeast cell wall products backed by extensive trial data. Chicory and sugar-beet processors such as BENEO (Südzucker group) and Tereos supply inulin and FOS ingredients, while dsm-firmenich Animal Nutrition & Health, Kemin Industries, Angel Yeast, ICC Brazil and Leiber participate through targeted glycans, beta-glucans and yeast-derived products. Recent strategic activity has centred on capacity investment in yeast derivatives, consolidation (including Lesaffre's joint venture with Zilor's Biorigin and Asahi Group Foods' agreement to acquire Leiber) and portfolio restructuring, such as dsm-firmenich's agreement to divest its Animal Nutrition & Health business to CVC Capital Partners.
Challenges and Opportunities
The principal challenges are the variability of response observed in field conditions, which complicates return-on-investment arguments with cost-focused feed buyers; exposure to the cost and availability of raw materials such as chicory root, sugar and yeast fermentation streams; and strong competition from alternative gut-health solutions including probiotics, organic acids, phytogenics and postbiotics. Opportunities lie in the expansion of commercial poultry and aquaculture in Asia Pacific, Latin America and Africa; the development of precision glycans and synbiotic combinations with clearer modes of action; the replacement of pharmacological zinc oxide in piglet diets in Europe; and wider use of microbiome analytics that allow suppliers to demonstrate measurable performance outcomes.
Future Outlook
Over 2026–2032 the market is expected to add USD 180.36 Million, reaching USD 600.49 Million. Product mix is projected to shift gradually toward the Others segment, whose share rises from 30.0% in 2025 to 32.8% in 2032, while Mannan Oligosaccharides retains the leading position at 37.8% in 2032. Poultry's share is projected to increase from 45.0% to 46.9%, and Asia Pacific's share from 32.0% to 34.0%, reflecting the concentration of future livestock production growth in developing economies.
The Feed Prebiotics Market market is projected to grow at a CAGR of 5.2% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Feed prebiotics are non-digestible or poorly digestible feed ingredients, predominantly oligosaccharides and polysaccharides, that resist hydrolysis by the animal's endogenous digestive enzymes and reach the lower gastrointestinal tract largely intact. There they selectively stimulate the growth or activity of beneficial microorganisms such as Lactobacillus and Bifidobacterium species, increase the production of short-chain fatty acids, and in the case of yeast-derived mannans, bind type-1 fimbriated pathogenic bacteria such as Escherichia coli and Salmonella, preventing their attachment to the intestinal wall. The resulting effects include improved gut integrity, nutrient utilisation, immune function and growth performance.
For the purpose of this study, the market comprises the following product categories, consistent with the segmentation used in the market data:
Mannan Oligosaccharides (MOS): yeast cell wall products and mannan-rich fractions obtained mainly from Saccharomyces cerevisiae, including products that also contain beta-glucans as part of the cell wall matrix.
Inulin & FOS: long-chain inulin and oligofructose extracted from chicory root, and short-chain fructo-oligosaccharides produced enzymatically from sucrose.
Others: other prebiotic oligosaccharides and polysaccharides used in animal feed, such as galacto-oligosaccharides, xylo-oligosaccharides, chito-oligosaccharides, isomalto-oligosaccharides, purified beta-glucans and targeted glycan products.
Inclusions: prebiotic ingredients sold for use in compound feed, premixes, concentrates, milk replacers and on-farm mixing, in dry or liquid form, for poultry, swine, ruminants, aquaculture and other farmed animals; and the prebiotic component of synbiotic products where it is sold as a defined prebiotic ingredient. Exclusions: probiotics (live microorganisms), feed enzymes, organic acids, phytogenic additives and antibiotics sold as standalone products; dietary fibre sources not marketed for their prebiotic function; and prebiotic ingredients used in human food, infant nutrition and dietary supplements. Market values are measured at the manufacturer or first-seller level.
Scope of the Study
The study analyses the Global Feed Prebiotics Market in terms of value (USD Million) across the following dimensions:
By Product Type: Mannan Oligosaccharides; Inulin & FOS; Others.
By Livestock: Poultry; Swine; Others.
By Region: North America (U.S., Canada, Mexico); Europe (Germany, U.K., France, Italy, Spain, Rest of Europe); Asia Pacific (China, India, Japan, Rest of Asia Pacific); Latin America (Brazil, Argentina, Rest of Latin America); Middle East & Africa (UAE, Saudi Arabia, South Africa, Rest of MEA).
Timeline: historic years 2022, 2023 and 2024; base year 2025; forecast period 2026–2032.
Currency and unit: USD Million; growth is expressed as the compound annual growth rate (CAGR) for 2026–2032.
Research Objectives
To estimate the size of the Global Feed Prebiotics Market for 2022–2025 and forecast it for 2026–2032 in USD Million.
To analyse the market by product type (Mannan Oligosaccharides, Inulin & FOS, Others) and identify the share and growth outlook of each segment.
To assess demand by livestock (Poultry, Swine, Others) and relate it to trends in animal protein production and antibiotic reduction.
To evaluate regional and country-level markets and identify the most attractive geographies for investment.
To examine the drivers, restraints, opportunities, trends and challenges shaping the adoption of prebiotics in animal feed.
To review the regulatory frameworks governing feed additives, feed materials and antimicrobial use in major regions.
To analyse the value chain and competitive intensity of the market using Porter's Five Forces and PESTEL frameworks.
To identify the leading companies, their positioning and their strategic developments from 2022 onward.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study follows a structured, multi-stage research process. It begins with a definition of the market scope and segmentation, followed by extensive secondary research to build an understanding of the product categories, application areas, regulatory environment and competitive landscape. Primary research with industry participants is then used to validate assumptions, refine segment splits and capture qualitative insight on demand trends. Market sizes are estimated using both top-down and bottom-up approaches, triangulated against each other and against independent indicators, and then projected over the forecast period using a factor-based forecasting model. Every stage includes internal quality checks for consistency between segments, regions and countries.
Stage 1: Scope definition, product taxonomy and segmentation framework.
Stage 2: Secondary research and compilation of the data repository.
Stage 3: Primary research for validation and qualitative insight.
Stage 4: Market size estimation, data triangulation and forecasting.
Stage 5: Analysis, quality review and report preparation.
Secondary Research
Secondary research draws on sources specific to the animal nutrition and feed additives industry, including:
Industry associations: feed industry federations and additive manufacturer associations at the global, regional and national level, including bodies representing compound feed producers and specialty feed ingredient suppliers.
Government and regulatory bodies: agriculture ministries, veterinary and food safety authorities, and feed additive registers and authorisation documents, together with livestock production and trade statistics published by national statistics offices and agricultural departments.
Intergovernmental organisations: livestock production, feed and meat consumption statistics and outlooks published by multilateral agricultural and animal health organisations.
Company filings and publications: annual reports, investor presentations, press releases, product literature and technical bulletins of feed additive, yeast, inulin and sugar processing companies.
Trade and scientific journals: feed industry trade publications and peer-reviewed literature on animal nutrition, gut microbiology and the efficacy of prebiotic supplementation.
Paid databases: trade and customs databases, company financial databases and industry production databases.
Primary Research
Primary research is conducted through in-depth telephone and online interviews with participants across the value chain. Its objectives are to validate the market size and segment splits derived from secondary research, understand purchasing criteria and pricing, assess the adoption of prebiotics across species and regions, and capture expert views on the outlook for the industry.
Supply side: manufacturers of yeast cell wall products, inulin and FOS, and other oligosaccharides; product managers, technical services and sales executives at feed additive companies; and distributors of specialty feed ingredients.
Demand side: nutritionists and procurement managers at compound feed manufacturers and premix producers; integrated poultry, swine and aquaculture producers; veterinarians; and academic researchers in animal nutrition.
Market Size Estimation
Top-down approach: the total market is derived from the value of the broader eubiotics and gut-health feed additives market, which is apportioned to prebiotics and then to product types, livestock segments and regions using penetration rates and share estimates obtained from secondary sources and validated by primary interviews.
Bottom-up approach: the market is built from compound feed production by species and country, multiplied by the share of feed containing prebiotics, typical inclusion rates for each product type and average selling prices. Country estimates are aggregated to regional and global totals, and supplier revenues are mapped to the segments where data permits.
Data triangulation: results from the two approaches are compared and reconciled. Differences are investigated and resolved through additional research and expert consultation, and the final estimates are checked for internal consistency so that segment, country and regional values sum to the corresponding totals.
Forecasting Methodology
Forecasts are developed by combining historic market trends with an assessment of the factors expected to influence demand over 2026–2032. The factors considered include projected growth in poultry, swine, ruminant and aquaculture production; compound feed output by region; the pace of antibiotic reduction and associated regulation; adoption rates of gut-health additives; price trends for prebiotic ingredients and their raw materials; the introduction of new products; and macroeconomic indicators such as GDP growth, population, income and meat consumption per capita. Each factor is weighted according to its expected impact during the forecast period, and the outputs are validated through primary interviews.
Base Year, Forecast Period and Currency
Historic years: 2022, 2023 and 2024.
Base year: 2025.
Forecast period: 2026–2032.
Currency: all values are presented in USD Million, at constant exchange rates.
Assumptions and Limitations
Regulatory frameworks restricting the use of antibiotics in animal feed remain in place and continue to tighten gradually in developing markets.
No major disruption to global livestock production is assumed beyond the disease outbreaks and trade frictions already observed during the historic period.
Average selling prices are assumed to remain broadly stable in real terms, with competition offsetting cost inflation.
Market values are estimated at the manufacturer level; values at distributor or end-user level will be higher.
Company-level revenues for prebiotic products are rarely disclosed separately, so supplier-based estimates depend on secondary information and expert judgement.
Unforeseen events such as major animal disease outbreaks, policy changes or extreme weather affecting raw material crops may cause actual outcomes to differ from the forecast.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The Global Feed Prebiotics Market is moderately fragmented. A limited number of international companies with strong positions in yeast fermentation, chicory processing and animal nutrition account for a significant part of branded product sales, while a large number of regional producers, particularly in China and other parts of Asia, supply generic yeast cell wall products and oligosaccharides at lower prices. The structure differs by product type: the Mannan Oligosaccharides segment is led by yeast specialists with integrated fermentation capacity; Inulin & FOS supply is concentrated among a small number of chicory and sugar processors; and the Others segment includes both large animal nutrition groups with targeted glycan technologies and numerous smaller oligosaccharide manufacturers.
Competition is based on scientific substantiation of product efficacy, consistency of active content, technical service and price. Leading suppliers invest in research partnerships, field trials and gut-health diagnostic services to differentiate their products, while expanding manufacturing capacity in growth regions. Since 2022, the competitive landscape has been reshaped by acquisitions, joint ventures and portfolio changes, including Lesaffre's joint venture with Biorigin, Asahi Group Foods' agreement to acquire Leiber, the formation of the Akralos feed joint venture by Alltech and ADM in North America, and dsm-firmenich's agreement to divest its Animal Nutrition & Health business to CVC Capital Partners.
Key Player Positioning
Based on their product portfolios, geographic reach, technical capabilities and strategic activity, the leading companies in the market can be grouped as follows:
Leaders: Alltech, Phileo by Lesaffre and Lallemand Animal Nutrition. These companies offer well-established branded yeast cell wall and mannan-rich products backed by large trial databases, global sales and technical service networks, and integrated yeast production.
Challengers: dsm-firmenich Animal Nutrition & Health, BENEO, Angel Yeast and ICC Brazil. These companies have strong positions in specific product types or regions, such as precision glycans, chicory inulin and oligofructose, or large-scale yeast derivative production in China and Brazil, and are investing to broaden their reach.
Niche players: Tereos, Leiber and Kemin Industries. These companies focus on specific products, such as short-chain FOS, brewers' yeast cell walls and algae-derived beta-glucan, within broader business portfolios.
Alltech, founded in 1980 and headquartered in Kentucky, pioneered the commercial use of mannan oligosaccharides with Bio-Mos and later introduced Actigen, a second-generation mannose-rich fraction; its yeast-based specialty ingredients remain a core platform. Phileo by Lesaffre, the animal nutrition and health division of the Lesaffre fermentation group, offers the Safmannan yeast cell wall range and has expanded its yeast derivative base through investments in production capacity and the 2025 joint venture with Biorigin. Lallemand Animal Nutrition combines its own yeast cell wall products with a long-term supply and research partnership with ICC Brazil. BENEO and Tereos are leading producers of chicory-based inulin and oligofructose and sugar-beet-based short-chain FOS respectively. Angel Yeast, one of the world's largest yeast producers, is expanding the international reach of its feed yeast products through overseas plants and subsidiaries.
Competitor Dashboard
The dashboard below rates the profiled companies on four dimensions relevant to competitiveness in feed prebiotics: the breadth and depth of their prebiotic product portfolio, their regional presence, their strategic alliances and their industry experience. Ratings are qualitative analyst assessments on a four-point scale (Low, Medium, High, Very High).
Bargaining Power of Suppliers – Medium
Chicory inulin supply is concentrated among a few processors, which gives these suppliers some pricing leverage.
Yeast-derived raw materials are available from multiple brewing, ethanol and yeast manufacturing sources, and many leading prebiotic producers are vertically integrated into fermentation.
Raw material prices are linked to agricultural commodities and energy, exposing manufacturers to cost fluctuations.
Bargaining Power of Buyers – High
Large integrators and compound feed manufacturers purchase in large volumes and run formal tenders and efficacy evaluations.
Buyers can switch between prebiotics and alternative gut-health additives, which increases their negotiating position.
Feed cost sensitivity in commodity livestock production results in strong price pressure on additives.
Threat of New Entrants – Medium
Basic yeast cell wall and oligosaccharide products can be produced with moderate capital investment, particularly by companies with access to fermentation by-products.
Regulatory registration, efficacy substantiation and established customer relationships create barriers to entry for branded products.
Leading companies benefit from extensive trial databases, technical service networks and global distribution.
Threat of Substitutes – High
Probiotics, organic acids, phytogenics, enzymes, medium-chain fatty acids and postbiotics address similar gut-health objectives.
In markets where regulation permits, antibiotics remain a lower-cost alternative for some producers.
Improved biosecurity, vaccination and management practices can reduce the perceived need for nutritional interventions.
Intensity of Competitive Rivalry – High
A mix of global fermentation specialists, ingredient processors and regional producers compete across product types.
Differentiation is based on scientific evidence, product consistency and technical support, while commoditised products compete on price.
Continued investment in capacity and consolidation through acquisitions and joint ventures intensify competition for key accounts.
Bargaining Power of Suppliers: Medium; Concentrated chicory supply offset by diverse yeast sources and vertical integration.
Bargaining Power of Buyers: High; Large, cost-focused integrators and feed mills with access to alternative additives.
Threat of New Entrants: Medium; Moderate capital needs but significant regulatory and scientific barriers.
Threat of Substitutes: High; Wide range of competing gut-health additives.
Competitive Rivalry: High; Global and regional suppliers competing on evidence, service and price.
Market estimates by geography (2032)
InsightAsia Pacific leads with $204.05M by 2032, while Middle East & Africa is projected to grow fastest at a 6.4% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $81.45M | $100.62M | $125.46M | 4.4% | 21% |
| Europe | $104.48M | $127.37M | $156.68M | 4.1% | 26% |
| Asia Pacific | $111.21M | $151.91M | $204.05M | 6.3% | 34% |
| Latin America | $45.77M | $61.46M | $81.73M | 6.0% | 14% |
| Middle East & Africa | $17.48M | $23.96M | $32.56M | 6.4% | 5% |
| Total | $360.39M | $465.31M | $600.49M | 5.2% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$600.49M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Mannan Oligosaccharides | $226.91M | 4.3% | 38% |
| Others | $197.12M | 6.7% | 33% |
| Inulin & FOS | $176.46M | 4.9% | 29% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Feed Prebiotics Market covering market dynamics, competitive landscape, and strategic outlook.
The Feed Prebiotics Market market is projected to reach $600.49M by 2032, growing at 5.2% CAGR. The Mannan Oligosaccharides segment holds the largest share.
The Global Feed Prebiotics Market is shaped by the interaction of regulatory, economic and technical forces. Policies that restrict the routine use of antibiotics in animal production have created sustained demand for non-antibiotic tools that support gut health, while rising consumption of poultry meat, pork, eggs, milk and farmed fish increases the volume of compound feed into which prebiotics can be incorporated. At the same time, cost pressure in commodity livestock production, variable field performance and competition from other gut-health additives temper the pace of adoption. This chapter assesses these forces, beginning with a structured growth factor analysis.
Market Growth Factor Analysis
The table below summarises five macro and five micro factors that influence the market, the direction of their impact and their relative strength over three periods of the forecast horizon. The impact scores, on a scale of 1 (very low) to 10 (very high), are analyst assessments based on secondary research and industry interviews, and are intended to indicate relative importance rather than precise measurements.
Restrictions on Antibiotic Use in Livestock Production
The progressive removal of antibiotics from routine use in animal feed is the single most important structural driver of the market. The European Union banned antibiotics as growth promoters from 1 January 2006 under Regulation (EC) No 1831/2003, and Regulation (EU) 2019/6 on veterinary medicinal products, applicable since 28 January 2022, further restricts prophylactic and metaphylactic use of antimicrobials. In the United States, the Food and Drug Administration's Guidance for Industry #213 ended the use of medically important antimicrobials for growth promotion from January 2017 and placed their remaining feed uses under veterinary oversight through the Veterinary Feed Directive. China's Ministry of Agriculture and Rural Affairs withdrew growth-promoting antibiotic additives from commercial feed under Announcement No. 194, effective July 2020, and India prohibited the use of colistin in food-producing animals in 2019. As these measures remove a tool that producers previously relied on to control sub-clinical enteric disease, feed formulators have turned to combinations of non-antibiotic additives, in which prebiotics such as mannan oligosaccharides and fructo-oligosaccharides play a central role by supporting a stable microbiota and limiting the colonisation of pathogenic bacteria.
Expanding Poultry and Livestock Production
Demand for animal protein continues to rise with population growth, urbanisation and higher incomes, particularly in Asia, Latin America, the Middle East and Africa. Poultry is the main beneficiary because of its short production cycle, efficient feed conversion and the absence of religious or cultural restrictions on its consumption, and the OECD-FAO Agricultural Outlook projects poultry meat to account for the largest share of the growth in global meat consumption over the coming decade. Expansion is concentrated in intensive, integrated operations that use commercially manufactured compound feed, which is the primary channel through which prebiotics reach the animal. Government programmes that promote domestic poultry self-sufficiency in markets such as Saudi Arabia, and the export-oriented growth of the Brazilian and Thai poultry industries, add further volume. Because inclusion rates of prebiotics are relatively stable per tonne of feed, growth in industrial feed output translates directly into higher demand, and this is reflected in Poultry being both the largest and fastest-growing livestock segment of the market.
Focus on Gut Health, Feed Efficiency and Animal Performance
Feed typically represents the largest single cost item in poultry and swine production, so improvements in feed conversion ratio, growth uniformity and mortality have a direct impact on producer margins. A large body of published research and commercial trial data shows that yeast cell wall products and fructans can improve intestinal morphology, modulate the immune response and reduce pathogen loads, with corresponding benefits for performance under commercial conditions. Producers have become more attentive to gut health as a determinant of overall productivity, especially during critical periods such as the starter phase in broilers and weaning in piglets. Suppliers increasingly support their products with technical services, including gut-health audits, microbiome analysis and on-farm trials, which helps nutritionists quantify the benefits and justifies the inclusion of prebiotics as a standard element of feeding programmes rather than an occasional remedy.
Consumer and Retail Demand for Antibiotic-Free Animal Products
Beyond regulation, consumer concern about antimicrobial resistance and food safety has led retailers, restaurant chains and food processors to adopt antibiotic sourcing policies, and integrators to launch "raised without antibiotics" and "no antibiotics ever" product lines. These programmes are most widespread in the North American and European broiler sectors but are spreading to pork, eggs and to export-oriented producers in Latin America and Asia that supply customers with such requirements. Meeting these specifications requires a robust package of preventive measures, including biosecurity, vaccination and nutritional tools, and prebiotics are one of the most widely used and best-documented components of that package. National action plans on antimicrobial resistance, developed in line with the One Health approach promoted by international organisations, further reinforce this direction and encourage the adoption of alternatives across a wider range of countries.
Growth of Aquaculture and Ruminant Applications
Aquaculture is one of the fastest-growing segments of animal protein production, and intensive shrimp and fish farming faces significant disease pressure with limited approved therapeutic options. Prebiotics such as MOS and beta-glucans are increasingly used in aquafeed to support immunity and survival. Ruminant applications, including calf milk replacers and dairy diets, offer a further avenue for growth. These uses fall within the Others livestock segment, which is projected to grow faster than the Swine segment over the forecast period.
Next-Generation Prebiotics and Synbiotic Combinations
Advances in carbohydrate chemistry and microbiome science are enabling the development of targeted oligosaccharides, purified beta-glucans and precision glycans designed to modulate specific microbial pathways. Combinations of prebiotics with probiotics (synbiotics) and with other additives offer suppliers a route to differentiated, higher-value products. These developments underpin the high growth rate of the Others product segment.
Penetration of Emerging Markets and Replacement of Zinc Oxide
Feed production in India, Southeast Asia, Africa and parts of Latin America is shifting from home-mixed to commercially manufactured compound feed, creating new channels for specialty additives as integrated producers adopt international practices. In Europe, the end of the use of veterinary medicinal products containing zinc oxide at therapeutic levels in piglet feed from June 2022 has created demand for alternative nutritional tools to manage post-weaning diarrhoea, for which prebiotics are among the solutions being adopted.
Variable Efficacy and Difficulty in Demonstrating Return on Investment
The response to prebiotic supplementation depends on factors such as diet composition, the animal's age and health status, environmental hygiene and the existing gut microbiota, so results observed in controlled trials are not always replicated in commercial settings. Product composition also varies, for example in the mannan and beta-glucan content of yeast cell wall products, which makes comparison between products difficult. In commodity production, where nutritionists evaluate every additive on cost per tonne of feed, an inconsistent or unmeasurable benefit can lead to prebiotics being removed from formulations when margins are under pressure, slowing penetration in price-sensitive markets.
Raw Material Price Volatility and Supply Constraints
Inulin and FOS depend on chicory root and sugar, whose supply is exposed to weather, crop yields and agricultural commodity prices, while yeast-derived products rely on by-product streams from brewing, ethanol and yeast manufacturing. Chicory processing capacity is concentrated in a small number of producers, mainly in Europe and Chile, which limits supply flexibility. Increases in energy and input costs feed through into product prices, which can reduce demand in markets where feed cost is the overriding purchasing criterion.
Competition from Alternative Gut-Health Solutions
Prebiotics compete for a limited additive budget with probiotics, organic acids, essential oils and other phytogenics, enzymes, medium-chain fatty acids and postbiotics. Many of these alternatives are promoted with similar claims, and feed manufacturers often select a limited number of additives for each formulation. This competition limits pricing power and can restrict the share of feed that contains a dedicated prebiotic.
Challenge: Substantiation of Claims and Regulatory Classification
Prebiotic products may be classified as feed materials or as feed additives depending on the jurisdiction and the claims made, and the claims that can be made for products sold as feed materials are limited. Obtaining authorisation for zootechnical claims requires extensive efficacy and safety dossiers, which involves significant time and cost and can delay market entry, particularly for smaller suppliers and new molecules.
Trend: Shift toward Integrated Gut-Health Programmes
Rather than relying on a single additive, nutritionists increasingly design gut-health programmes that combine prebiotics with probiotics, organic acids, phytogenics and enzymes, often adapted by production phase. Suppliers respond by offering multi-component solutions and technical support, positioning prebiotics as part of a broader programme.
Trend: Upcycling of Yeast and Agro-Industrial Side Streams
Producers are investing in the recovery of yeast cell walls and other fractions from brewing, bioethanol and yeast extract production. This improves the sustainability profile of prebiotic products and secures raw material supply. Investments in Brazil, where yeast from sugarcane ethanol fermentation is abundant, and acquisitions of brewers' yeast processors illustrate this trend.
Trend: Consolidation and Portfolio Restructuring
The supplier landscape has undergone significant change since 2022, including joint ventures and acquisitions in yeast derivatives and the restructuring of large animal nutrition businesses. Consolidation is expected to continue as companies seek scale in fermentation, broader portfolios and access to growing regional markets.
The value chain of the Global Feed Prebiotics Market extends from agricultural and fermentation raw materials to the livestock producer. Value addition is concentrated in the processing and formulation stage, where purification, standardisation and scientific substantiation differentiate branded products from commodity ingredients.
Raw materials and inputs: chicory root and sugar (sucrose) for inulin and FOS; yeast biomass from brewing, bioethanol, baker's yeast and yeast extract production for MOS and beta-glucans; lactose for galacto-oligosaccharides; and lignocellulosic materials such as corncobs for xylo-oligosaccharides. Supply is influenced by agricultural yields and by the operating rates of the industries that generate by-products.
Manufacturing and processing: extraction and refining of inulin from chicory; enzymatic synthesis of short-chain FOS from sucrose; autolysis, separation, washing and drying of yeast cell walls; enzymatic or chemical hydrolysis and fractionation to concentrate mannans and beta-glucans; and spray drying, granulation and standardisation to guaranteed active content. Manufacturers also invest in research, efficacy trials and regulatory dossiers.
Distribution and channels: direct sales to large integrators, compound feed manufacturers and premix producers; sales through specialty feed ingredient distributors and agents in fragmented markets; and supply to premix and concentrate manufacturers that incorporate prebiotics into blended products. Technical service is an important part of the commercial offer.
End users: compound feed mills, integrated poultry, swine, dairy and aquaculture producers, independent farms using concentrates or on-farm mixing, and calf milk replacer manufacturers.
North America
United States: animal food ingredients are regulated by the Food and Drug Administration's Center for Veterinary Medicine under the Federal Food, Drug, and Cosmetic Act. Ingredients may enter the market as approved food additives, through Generally Recognized as Safe (GRAS) notices, or through ingredient definitions recognised in the Official Publication of the Association of American Feed Control Officials (AAFCO). State feed control officials enforce labelling and registration requirements.
Antimicrobial policy (U.S.): FDA Guidance for Industry #209 and #213 ended the use of medically important antimicrobials for growth promotion in food animals from January 2017, and the Veterinary Feed Directive requires veterinary authorisation for their use in feed. Guidance for Industry #263 moved the remaining over-the-counter medically important antimicrobials to prescription status in June 2023.
Canada: feeds are regulated by the Canadian Food Inspection Agency under the Feeds Act and its regulations, which govern the approval and registration of feed ingredients. Health Canada removed growth promotion claims from medically important antimicrobials in December 2018.
Mexico: feed products are regulated by the National Service of Agri-Food Health, Safety and Quality (SENASICA) under the Ministry of Agriculture and Rural Development (SADER).
Europe
Regulation (EC) No 1831/2003 governs the authorisation, supervision and labelling of feed additives, including zootechnical additives such as gut flora stabilisers, following a scientific assessment by the European Food Safety Authority (EFSA). It also prohibited the use of antibiotics as growth promoters from 1 January 2006.
Regulation (EC) No 767/2009 sets the rules for the placing on the market and use of feed, and Regulation (EU) No 68/2013 establishes the Catalogue of feed materials, under which several yeast products and fructan sources are listed.
Regulation (EC) No 183/2005 lays down feed hygiene requirements for all feed business operators.
Regulations (EU) 2019/6 and 2019/4 on veterinary medicinal products and medicated feed, applicable from 28 January 2022, restrict preventive antimicrobial use. The use of veterinary medicinal products containing zinc oxide at therapeutic levels ended in June 2022.
United Kingdom: following its exit from the EU, Great Britain operates its own feed additive authorisation process overseen by the Food Standards Agency, based on retained EU legislation.
Asia Pacific
China: feed and feed additives are regulated under the State Council's Regulations on the Administration of Feed and Feed Additives, and only substances listed in the Feed Additive Catalogue issued by the Ministry of Agriculture and Rural Affairs (MARA) may be used. MARA Announcement No. 194 withdrew growth-promoting antibiotic additives from commercial feed from July 2020.
India: the Bureau of Indian Standards publishes specifications for compounded feeds, including IS 1374 for poultry feeds and IS 2052 for cattle feeds. The Ministry of Health and Family Welfare prohibited colistin and its formulations for food-producing animals, poultry and aqua farming in 2019.
Japan: feeds and feed additives are regulated under the Act on Safety Assurance and Quality Improvement of Feeds, administered by the Ministry of Agriculture, Forestry and Fisheries (MAFF), with inspection by the Food and Agricultural Materials Inspection Center (FAMIC).
Latin America
Brazil: the Ministry of Agriculture and Livestock (MAPA) regulates feed products and additives, including registration of establishments and products, under Decree No. 6,296/2007 and related normative instructions. MAPA has prohibited the use of several antimicrobials as growth promoters, including colistin in 2016.
Argentina: the National Agri-Food Health and Quality Service (SENASA) is responsible for the registration and control of animal feed products.
Middle East & Africa
Saudi Arabia: the Saudi Food and Drug Authority (SFDA) regulates the registration and safety of animal feed and feed additives.
United Arab Emirates: the Ministry of Climate Change and Environment (MOCCAE) oversees animal feed regulation and import controls.
South Africa: farm feeds are registered under the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act (Act No. 36 of 1947), administered by the Department of Agriculture.
The table below lists key launches, acquisitions, partnerships, investments and expansions by the profiled companies from 2022 onward.
Feb 2022: Phileo by Lesaffre; Investment; Announced investment in a new factory in Valladolid, Spain, for the production of its selenium-enriched yeast Selsaf.
Oct 2022: DSM (now dsm-firmenich); Product Launch; Introduced Symphiome, a targeted glycan "precision biotic" for poultry, developed from its 2021 acquisition of Midori USA.
May 2023: Alltech; Acquisition; Acquired a majority stake in Agolin, a Swiss producer of plant-based feed additives.
Jun 2023: Phileo by Lesaffre; Expansion; Inaugurated its new Selsaf production facility in Valladolid, Spain.
Sep 2023: Tereos and Lallemand; Product Launch; Launched Profeed ADVANCED, combining short-chain FOS with yeast fractions to support immunity in ageing dogs.
Nov 2023: Lesaffre (Phileo); Investment; Installed a new dryer at its Cedar Rapids, Iowa, yeast extract plant to support the growth of Phileo.
Nov 2023: BENEO; Expansion; Extended its Pemuco, Chile, facility to produce liquid Orafti oligofructose, part of a programme to raise chicory root fibre capacity.
2024: Angel Yeast; Expansion; Established subsidiaries in Algeria and Brazil as part of its overseas yeast business expansion.
May 2024: Lallemand Animal Nutrition; Investment; Invested in its selenized yeast production plant in Felixstowe, U.K.
Oct 2024: Lesaffre; Acquisition; Agreed to acquire a 70% stake in Biorigin from Zilor for BRL 665 million.
Oct 2024: Lallemand Animal Nutrition; Partnership; Established a joint laboratory with the Micalis Institute focused on beneficial microbes.
Mar 2025: Asahi Group Foods (Leiber); Acquisition; Signed an agreement to acquire 100% of Leiber GmbH, a German processor of brewers' yeast products for feed and food.
Apr 2025: ICC Brazil; Expansion; Expanded capacity at its animal nutrition plant in Jundiaí, São Paulo state.
Jun 2025: Lesaffre and Zilor; Joint Venture; Completed the Biorigin transaction, forming a joint venture in yeast derivatives for food and feed.
Jun 2025: dsm-firmenich; Divestment; Completed the sale of its stake in the Feed Enzyme Alliance to Novonesis for EUR 1.5 billion.
Sep 2025: Angel Yeast; Product Launch; Presented its YeaMOS yeast cell wall and other yeast-based animal nutrition products at ILDEX Indonesia 2025.
Sep 2025: Kemin Industries; Acquisition; Acquired CJ Youtell Biotech, including enzyme and fermentation plants in China.
Feb 2026: Alltech and ADM; Joint Venture; Launched Akralos, a North American animal feed joint venture majority-owned by Alltech.
Feb 2026: dsm-firmenich; Divestment; Agreed to sell its Animal Nutrition & Health business to CVC Capital Partners at an enterprise value of approx. EUR 2.2 billion.
Mar 2026: Phileo by Lesaffre; Partnership; Entered a long-term partnership with Agronutris on microbial solutions for the insect farming industry.
Jul 2026: Lallemand Animal Nutrition; Acquisition; Acquired BIO-CAT, a U.S. producer of enzymes and probiotics with two U.S. manufacturing plants.
Sep 2026: Lallemand Animal Nutrition; Partnership; Formed the SCAN research partnership with CCPA Group and IRSET.
Political
National action plans on antimicrobial resistance and One Health policies encourage the adoption of antibiotic alternatives in livestock production.
Food security and livestock self-sufficiency programmes, particularly in the Gulf states and Asia, support investment in modern, feed-intensive production.
Trade policies and sanitary restrictions on meat exports influence production levels in exporting countries such as Brazil, the U.S. and the EU member states.
Economic
Feed grain and soybean meal price cycles affect producer margins and the budget available for specialty additives.
Rising incomes in emerging economies increase per capita consumption of poultry, pork, eggs and dairy products.
Energy and agricultural commodity prices influence the production cost of inulin, FOS and yeast-derived products.
Social
Consumer concern about antimicrobial resistance and food safety supports demand for antibiotic-free meat and eggs.
Growing attention to animal welfare favours nutritional tools that support animal health and robustness.
Dietary shifts toward poultry and aquaculture products increase demand in the fastest-growing livestock segments.
Technological
Microbiome sequencing and gut-health diagnostics allow more precise evaluation of prebiotic effects.
Advances in enzymatic synthesis, fractionation and purification improve product consistency and enable new oligosaccharides.
Development of precision glycans and synbiotics creates differentiated, higher-value products.
Environmental
Upcycling of yeast and agro-industrial side streams into prebiotics supports circular economy objectives.
Improved feed efficiency can reduce the environmental footprint per unit of animal protein produced.
Climate variability affects chicory, sugar beet and sugarcane yields, influencing raw material availability.
Legal
Feed additive authorisation frameworks, such as Regulation (EC) No 1831/2003, require scientific dossiers and limit permissible claims.
Restrictions on growth-promoting and preventive antimicrobial use, in force in the EU, U.S., China and other markets, create sustained demand for alternatives.
Labelling and feed hygiene regulations impose quality and traceability obligations on manufacturers and distributors.
Profiles of 105 companies operating in the Feed Prebiotics Market market, including revenue, employee count, and market positioning where available.
Showing 105 of 105 companies
DuPont de Nemours today is a focused, roughly USD 7 bn-revenue multi-industry company. It is no longer the diversified chemical conglomerate of its heritage. After a decade of portfolio surgery, the company consists of two segments: **Healthcare & Water Technologies (about 47% of FY2025 sales):** Tyvek® medical packaging and protective garments, specialty medical device components (Spectrum, Donatelle), and the FilmTec™ / Amberlite™ water purification franchise. **Diversified Industrials (about 53%):** Building envelope products (Tyvek® house wrap, Styrofoam™, Corian®) and engineered industrial technologies (Molykote®, Vespel®, Betaseal™/Betaforce™ adhesives, Cyrel® printing plates). The company earns a premium-specialty margin profile: operating EBITDA margin was 23.8% in FY2025, with guidance of about 24.5% for FY2026. Management targets 3–4% organic growth, 150–200 bps of margin expansion and 8–10% adjusted EPS CAGR through 2028, supported by a lightly levered BBB+/Baa1 balance sheet. The principal overhang is legacy PFAS liability, shared with Chemours, Corteva and Qnity under contractual arrangements. The principal opportunity is a cleaner, higher-growth healthcare/water mix and capital redeployment. --- **Company's own description (FY2025 10-K, Item 1).** DuPont describes itself as a leading provider of advanced solutions that improve everyday life across healthcare, water, construction and industrial markets. It emphasizes helping customers advance their technology pipelines, from clean water to medical packaging that enhances safety and performance. It names its competitive strengths as: - proprietary product and process technologies; - robust application-development pipelines; - well-known brands; - customer intimacy; - global manufacturing and local service capability. **Independent characterization.** DuPont is now best understood as a specialty engineered-materials and components company with four businesses of roughly comparable scale: **Business model and revenue model.** - Revenue is overwhelmingly product sales: materials, components, membranes, resins, garments and plates. Some engineered systems and modules are sold in Water. - There is no material subscription or licensing revenue. Trade secrets may be licensed occasionally (10-K, Intellectual Property). - The contract manufacturing and design services of Spectrum and Donatelle (medical devices) add a design-in / build-to-print services element, but are recognized as product revenue. - Seasonality: North American Building Technologies demand peaks in Q2–Q3. **Value-chain position.** DuPont sits mid-stream as a Tier-1/Tier-2 supplier. It converts purchased raw materials (polyolefins, specialty monomers, resins, silicones, polymers) into engineered materials, membranes and components. These are specified into customers' finished products: medical devices, sterile packaging, water plants, building envelopes, aircraft, vehicles and print packaging. **Customer types.** - Medical device OEMs and sterile packaging converters - Biopharma manufacturers - Industrial end users and EPC/OEM water-system integrators - Municipalities and desalination operators (via integrators) - Builders, contractors and distributors (e.g., Corian® distribution through Hallmark and Parksite) - Automotive and EV OEMs and Tier-1s - Aerospace OEMs - Printing and packaging converters Most products are sold through DuPont's own sales organization, with distributors used for some lines (10-K, Distribution). **End markets.** Healthcare (medical devices, packaging, biopharma, PPE), water (industrial, municipal/desalination, life sciences, microelectronics UPW), construction (residential, non-residential, repair/remodel) and industrial (aerospace, automotive/EV, printing and packaging, general industrial).
3 interactive charts drawn from the Feed Prebiotics Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Feed Prebiotics Market By Livestock
Global Feed Prebiotics Market By Product Type
Global Feed Prebiotics Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
